Navigating regulatory affairs challenges for successful drugs

New drugs have to go through a long process of drug development before they reach the market. Along their manufacturing journey, many regulatory challenges arise that any successful drug has to pass in order to reach patients in a timely, safe and reliable manner. Join our RA expert webinar to learn how Bachem accompanies our customers and makes sure to satisfy the demand of regulatory agencies.

About the Speakers

Anja Erdin

Expert Manager RA

Anja Erdin completed her German State exam in food chemistry and received her official certification as Food chemist from CVUA Münster in 2001. She joined Bachem as a regulatory affairs specialist and became a group leader in 2009. As a group leader, she focused on NCE Development and assisting customers with navigating regulatory challenges throughout the lifecycle of their product.

Tycho Leifels

Director Product Management

Dr. Tycho Leifels received his PhD in organic chemistry from the University in Basel in 1999 and got his start in industry as product manager at Pfizer. He became group product manager at Mepha in 2005 and moved into more strategic positions, acting as director of Marketing, Portfolio management, Pipeline and Strategy Management for various pharmaceutical companies before his current position as group leader Product Management at Bachem.

03 August 2026

Navigating regulatory affairs challenges for successful drugs

About the Speakers

Related Articles

Case study: Verification of SAX method selectivity using 2D-LC-MS for peak purity assessment of oligonucleotide APIs

API contract manufacturing: Process, benefits, and partner selection

What is Tag-Assisted Peptide Synthesis (TAPS)?

Looking for more information?